NORVARA THERAPEUTICS

London
Computational Virology & Gene Therapy

Norvara Therapeutics is a computational biology firm solving the delivery problem in gene therapy. We use generative artificial intelligence and structural biology to redesign viral capsids so a treatment reaches the precise target cells, slips past the body's immune defences, and can be manufactured at scale.

A Message from the Partners:

We allocate our capital toward rigorous science rather than marketing. As a computational-first enterprise, we generate intellectual property in-silico, while our academic partners run the biological assays. If you are an institutional investor or academic research group inquiring about collaboration or our seed round, please review our Platform Philosophy before contacting us. We do not engage in speculative software consulting.

If you have any comments about our research or wish to propose a wet-lab partnership, you can write us at research@norvaratx.com. We aim to respond within 3 business days. However, due to the strict volume of correspondence we receive, we can't guarantee a response.